Osteocytic FSH inhibition rescues bone mass and boosts fracture healing in ovariectomized mice
Life Sciences · 2026
DOI: 10.1016/j.lfs.2025.124121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2026. Verfasst von Zemin Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China. Hauptthemen laut MEDLINE: Receptors, FSH, Fracture Healing, Follicle Stimulating Hormone, Osteocytes. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
AIMS: Postmenopausal osteoporosis significantly increases fragility fracture risk. While menopausal estrogen decline coincides with rising follicle-stimulating hormone (FSH), the role of circulating FSH in bone loss remains unclear. This study investigates the direct function of FSH and FSH receptor (FSHR) in bone, focusing on osteocyte-mediated mechanisms. MATERIALS AND METHODS: To probe FSHR function, osteocyte-specific Fshr knockout mice (Dmp1-CreERT; Fshrfl/fl) were generated. Following ovariectomy, Fshr deletion was induced with tamoxifen. We performed RNA-sequencing on femoral cortical bone, validated by digital PCR and ELISA. In vitro assays assessed FSH's effect on PI3K/Akt signaling and osteogenic mineralization. Fracture healing and biomechanics were evaluated using a closed femoral fracture model and three-point bending. KEY FINDINGS: Osteocyte-specific Fshr knockout enhanced bone mineralization, resorption, and formation-resorption coupling, activating the PI3K/Akt pathway. Fshr deletion blocked FSH-mediated PI3K/Akt inhibition and restored osteogenic mineralization in vitro. Knockout mice showed accelerated callus maturation and improved biomechanical healing post-fracture. SIGNIFICANCE: We identify osteocytes as direct FSH target cells. Osteocyte Fshr deletion promotes bone turnover and accelerates fracture repair in ovariectomized mice by enhancing PI3K/Akt signaling. These findings reveal a new pathophysiological mechanism for postmenopausal osteoporosis and suggest a promising therapeutic strategy targeting FSHR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
- School of Basic Medicine, Shanxi Medical University, Taiyuan, Shanxi, China.
- School of Basic Medicine, Shanxi Medical University, Taiyuan, Shanxi, China; Department of Pathology and Physiology, School of Basic Medicine, Peking University, Peking, China.
- Department of Ultrasound, Second Hospital of Shanxi Medical University, Taiyuan, 030001, China.
- Department of Orthopaedics, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China. Electronic address: yhzhy@sxmu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, Z., Sun, M., Zhou, H., Cheng, L., Li, X., Chen, B., Wang, C., Li, C., Wang, D., Li, Y., Li, J., & Zhang, Y. (2026). Osteocytic FSH inhibition rescues bone mass and boosts fracture healing in ovariectomized mice. Life Sciences. https://doi.org/10.1016/j.lfs.2025.124121
Vancouver
Liu Z, Sun M, Zhou H, Cheng L, Li X, Chen B, et al. Osteocytic FSH inhibition rescues bone mass and boosts fracture healing in ovariectomized mice. Life Sciences. 2026. doi:10.1016/j.lfs.2025.124121
BibTeX
@article{Liu2026,
author = {Liu, Zemin and Sun, Mingxin and Zhou, Hongjie and Cheng, Liben and Li, Xiaoli and Chen, Bin and Wang, Chaoqi and Li, Chao and Wang, Dong and Li, Yan and Li, Juan and Zhang, Yonghong},
title = {Osteocytic FSH inhibition rescues bone mass and boosts fracture healing in ovariectomized mice},
journal = {Life Sciences},
year = {2026},
doi = {10.1016/j.lfs.2025.124121}
}
EUVIMED